Molecular consequences of drug bioactivation
Main Author: | |
---|---|
Published: |
University of Liverpool
2002
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.269600 |
id |
ndltd-bl.uk-oai-ethos.bl.uk-269600 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-bl.uk-oai-ethos.bl.uk-2696002015-03-19T07:36:07ZMolecular consequences of drug bioactivationO'Donnell, Charles John Lawrence2002615ClozapineUniversity of Liverpoolhttp://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.269600Electronic Thesis or Dissertation |
collection |
NDLTD |
sources |
NDLTD |
topic |
615 Clozapine |
spellingShingle |
615 Clozapine O'Donnell, Charles John Lawrence Molecular consequences of drug bioactivation |
author |
O'Donnell, Charles John Lawrence |
author_facet |
O'Donnell, Charles John Lawrence |
author_sort |
O'Donnell, Charles John Lawrence |
title |
Molecular consequences of drug bioactivation |
title_short |
Molecular consequences of drug bioactivation |
title_full |
Molecular consequences of drug bioactivation |
title_fullStr |
Molecular consequences of drug bioactivation |
title_full_unstemmed |
Molecular consequences of drug bioactivation |
title_sort |
molecular consequences of drug bioactivation |
publisher |
University of Liverpool |
publishDate |
2002 |
url |
http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.269600 |
work_keys_str_mv |
AT odonnellcharlesjohnlawrence molecularconsequencesofdrugbioactivation |
_version_ |
1716757274696876032 |